Cargando…

Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model

INTRODUCTION: Triamcinolone acetonide (TA), a steroid, is often used clinically to prevent dysfunctions associated with fibrosis. The objective of this study was to examine whether TA can be suspended in a gelatin sheet for tissue engineering using a mouse skin wound model. METHODS: TA was suspended...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Nao, Hashimoto, Satoru, Sato, Hiroki, Takahashi, Kazuya, Nagoya, Takuro, Kamimura, Kenya, Tsuchiya, Atsunori, Yokoyama, Junji, Sato, Yuichi, Wakatsuki, Hanako, Miyata, Masayuki, Akashi, Yusuke, Tanaka, Ryusuke, Matsuda, Ken, Tabata, Yasuhiko, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518320/
https://www.ncbi.nlm.nih.gov/pubmed/31193122
http://dx.doi.org/10.1016/j.reth.2019.04.001
_version_ 1783418433482784768
author Nakajima, Nao
Hashimoto, Satoru
Sato, Hiroki
Takahashi, Kazuya
Nagoya, Takuro
Kamimura, Kenya
Tsuchiya, Atsunori
Yokoyama, Junji
Sato, Yuichi
Wakatsuki, Hanako
Miyata, Masayuki
Akashi, Yusuke
Tanaka, Ryusuke
Matsuda, Ken
Tabata, Yasuhiko
Terai, Shuji
author_facet Nakajima, Nao
Hashimoto, Satoru
Sato, Hiroki
Takahashi, Kazuya
Nagoya, Takuro
Kamimura, Kenya
Tsuchiya, Atsunori
Yokoyama, Junji
Sato, Yuichi
Wakatsuki, Hanako
Miyata, Masayuki
Akashi, Yusuke
Tanaka, Ryusuke
Matsuda, Ken
Tabata, Yasuhiko
Terai, Shuji
author_sort Nakajima, Nao
collection PubMed
description INTRODUCTION: Triamcinolone acetonide (TA), a steroid, is often used clinically to prevent dysfunctions associated with fibrosis. The objective of this study was to examine whether TA can be suspended in a gelatin sheet for tissue engineering using a mouse skin wound model. METHODS: TA was suspended in biodegradable gelatin and freeze-dried in a sheet form. The sheet was analyzed for homogeneity and controlled release of TA by high-performance liquid chromatography. We made two skin wounds on the dorsal side of mice. Gelatin sheets with TA (TA sheet) and without TA (control sheet) were attached to each skin wound. To determine the efficacy of the prepared TA sheet on the skin wounds, TA-sheet versus TA-injection experiments were conducted. Hematoxylin and eosin staining was performed to assess the grade of epithelialization and alpha smooth muscle actin (α-SMA) immunohistochemical staining was conducted to evaluate myofibroblast infiltration. RESULTS: In the TA-release test in vitro, 7.7 ± 2.3% of TA was released from the sheet by 24 h. After replacing the initial phosphate-buffered saline (PBS) with collagenase PBS, the amount of released TA increased over time. The wound area/original skin wound area after 15 days with the TA sheet was significantly larger than that with the control sheet (26.9 ± 5.5% vs 10.7 ± 2.6%, p = 0.023). The α-SMA positive area/whole area with the TA sheet was significantly lower than that with the control sheet (4.65 ± 0.66% vs 7.24 ± 0.7%, p = 0.023). Furthermore, the α-SMA positive area/whole area with the TA sheet was significantly lower than that with TA injection (5.32 ± 0.45% vs 7.93 ± 0.75%, p = 0.013). CONCLUSIONS: We developed a TA sheet and confirmed both the homogeneity of the suspended TA and controlled-release of the TA in the presence of collagenase in vitro. The TA sheet caused less myofibroblast infiltration into the tissue than the control sheet or TA injection did.
format Online
Article
Text
id pubmed-6518320
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Japanese Society for Regenerative Medicine
record_format MEDLINE/PubMed
spelling pubmed-65183202019-05-21 Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model Nakajima, Nao Hashimoto, Satoru Sato, Hiroki Takahashi, Kazuya Nagoya, Takuro Kamimura, Kenya Tsuchiya, Atsunori Yokoyama, Junji Sato, Yuichi Wakatsuki, Hanako Miyata, Masayuki Akashi, Yusuke Tanaka, Ryusuke Matsuda, Ken Tabata, Yasuhiko Terai, Shuji Regen Ther Original Article INTRODUCTION: Triamcinolone acetonide (TA), a steroid, is often used clinically to prevent dysfunctions associated with fibrosis. The objective of this study was to examine whether TA can be suspended in a gelatin sheet for tissue engineering using a mouse skin wound model. METHODS: TA was suspended in biodegradable gelatin and freeze-dried in a sheet form. The sheet was analyzed for homogeneity and controlled release of TA by high-performance liquid chromatography. We made two skin wounds on the dorsal side of mice. Gelatin sheets with TA (TA sheet) and without TA (control sheet) were attached to each skin wound. To determine the efficacy of the prepared TA sheet on the skin wounds, TA-sheet versus TA-injection experiments were conducted. Hematoxylin and eosin staining was performed to assess the grade of epithelialization and alpha smooth muscle actin (α-SMA) immunohistochemical staining was conducted to evaluate myofibroblast infiltration. RESULTS: In the TA-release test in vitro, 7.7 ± 2.3% of TA was released from the sheet by 24 h. After replacing the initial phosphate-buffered saline (PBS) with collagenase PBS, the amount of released TA increased over time. The wound area/original skin wound area after 15 days with the TA sheet was significantly larger than that with the control sheet (26.9 ± 5.5% vs 10.7 ± 2.6%, p = 0.023). The α-SMA positive area/whole area with the TA sheet was significantly lower than that with the control sheet (4.65 ± 0.66% vs 7.24 ± 0.7%, p = 0.023). Furthermore, the α-SMA positive area/whole area with the TA sheet was significantly lower than that with TA injection (5.32 ± 0.45% vs 7.93 ± 0.75%, p = 0.013). CONCLUSIONS: We developed a TA sheet and confirmed both the homogeneity of the suspended TA and controlled-release of the TA in the presence of collagenase in vitro. The TA sheet caused less myofibroblast infiltration into the tissue than the control sheet or TA injection did. Japanese Society for Regenerative Medicine 2019-05-10 /pmc/articles/PMC6518320/ /pubmed/31193122 http://dx.doi.org/10.1016/j.reth.2019.04.001 Text en © 2019 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Nakajima, Nao
Hashimoto, Satoru
Sato, Hiroki
Takahashi, Kazuya
Nagoya, Takuro
Kamimura, Kenya
Tsuchiya, Atsunori
Yokoyama, Junji
Sato, Yuichi
Wakatsuki, Hanako
Miyata, Masayuki
Akashi, Yusuke
Tanaka, Ryusuke
Matsuda, Ken
Tabata, Yasuhiko
Terai, Shuji
Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model
title Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model
title_full Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model
title_fullStr Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model
title_full_unstemmed Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model
title_short Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model
title_sort efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518320/
https://www.ncbi.nlm.nih.gov/pubmed/31193122
http://dx.doi.org/10.1016/j.reth.2019.04.001
work_keys_str_mv AT nakajimanao efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT hashimotosatoru efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT satohiroki efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT takahashikazuya efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT nagoyatakuro efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT kamimurakenya efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT tsuchiyaatsunori efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT yokoyamajunji efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT satoyuichi efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT wakatsukihanako efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT miyatamasayuki efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT akashiyusuke efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT tanakaryusuke efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT matsudaken efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT tabatayasuhiko efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel
AT teraishuji efficacyofgelatinhydrogelsincorporatingtriamcinoloneacetonideforpreventionoffibrosisinamousemodel